Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Biomedical Science|April 23, 2021
Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinomaYi-Chieh Yang, Ming-Hsien Chien, Tsung-Ching Lai, et al.
Cancers|April 12, 2022
Characterization of Aberrations in DNA Damage Repair Pathways in Gastrointestinal Stromal Tumors: The Clinicopathologic Relevance of γH2AX and 53BP1 in Correlation with Heterozygous Deletions of CHEK2, BRCA2, and RB1Ting-Ting Liu, Chien-Feng Li, Kien-Thiam Tan, et al.
Bioorganic Chemistry|June 7, 2019
Phototoxicity of 7-oxycoumarins with keratinocytes in cultureChristophe Guillon, Yi-Hua Jan, Diane E Heck, et al.
Toxicology and Applied Pharmacology|September 18, 2018
Quinone and nitrofurantoin redox cycling by recombinant cytochrome b5 reductaseJohn T Szilagyi, Karma C Fussell, Yun Wang, et al.
Annals of Surgical Oncology|July 11, 2013
Expression of GOLM1 correlates with prognosis in human hepatocellular carcinomaMing-Huang Chen, Yi-Hua Jan, Peter Mu-Hsin Chang, et al.
American Journal of Respiratory and Critical Care Medicine|April 24, 2015
CARMA3 Represses Metastasis Suppressor NME2 to Promote Lung Cancer Stemness and MetastasisYi-Wen Chang, Ching-Feng Chiu, Kang-Yun Lee, et al.
International Journal of Molecular Sciences|July 13, 2024
TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and IpilimumabBunpei Isoda, Shuya Kandori, Tomokazu Sazuka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2015
Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P ProteinMing-Hsien Chien, Wei-Jiunn Lee, Feng-Koo Hsieh, et al.
Molecular Cancer|August 14, 2014
The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasisKuo-Tai Hua, Ming-Yang Wang, Min-Wei Chen, et al.
Cancer Research|September 25, 2012
Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3Yi-Hua Jan, Hong-Yuan Tsai, Chih-Jen Yang, et al.
Pageof 7